Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins

Subcutaneous Administration ◽

Low Molecular Weight ◽

Tissue Factor Pathway ◽

Partial Depletion

Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin

Thrombosis Research ◽

10.1016/s0049-3848(00)00351-0 ◽

2000 ◽

Vol 100 (5) ◽

pp. 413-417 ◽

Cited By ~ 14

Author(s):

John-Bjarne Hansen ◽

Trine Naalsund ◽

Per Morten Sandset ◽

Birgit Svensson

Keyword(s):

Molecular Weight ◽

Unfractionated Heparin ◽

Tissue Factor ◽

Low Molecular Weight ◽

Tissue Factor Pathway ◽

Partial Depletion

Efficacy of Unfractionated Heparin, Low Molecular Weight Heparin and Both Combined for Releasing Total and Free Tissue Factor Pathway Inhibitor

Pathophysiology of Haemostasis and Thrombosis ◽

10.1159/000022436 ◽

1998 ◽

Vol 28 (5) ◽

pp. 229-235 ◽

Cited By ~ 1

Author(s):

Raul Altman ◽

Alejandra Scazziota ◽

Jorge Rouvier

Keyword(s):

Molecular Weight ◽

Unfractionated Heparin ◽

Tissue Factor ◽

Low Molecular Weight ◽

Differential Effects of Low Molecular Weight Heparin and Unfractionated Heparin on Circulating Levels of Antithrombin and Tissue Factor Pathway Inhibitor (TFPI)

Thrombosis Research ◽

10.1016/s0049-3848(98)00079-6 ◽

1998 ◽

Vol 91 (4) ◽

pp. 177-181 ◽

Cited By ~ 30

Author(s):

John-Bjarne Hansen ◽

Per Morten Sandset

Keyword(s):

Molecular Weight ◽

Unfractionated Heparin ◽

Tissue Factor ◽

Low Molecular Weight ◽

Differential Effects ◽

Tissue Factor Pathway ◽

Circulating Levels

Tissue factor pathway inhibitor release is specific for heparin and low molecular weight heparins. Implications in the management of coronary syndromes

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(98)80877-2 ◽

1998 ◽

Vol 31 ◽

pp. 53

Author(s):

D. Hoppensteadt ◽

J. Fareed ◽

J. Amiral ◽

W. Jeske ◽

J.M. Walenga ◽

...

Keyword(s):

Molecular Weight ◽

Tissue Factor ◽

Low Molecular Weight ◽

Coronary Syndromes ◽

Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins

Blood Coagulation & Fibrinolysis ◽

10.1097/00001721-200006000-00005 ◽

2000 ◽

Vol 11 (4) ◽

pp. 343-348 ◽

Cited By ~ 18

Author(s):

B. Bendz ◽

T. O. Andersen ◽

P. M. Sandset

Keyword(s):

Molecular Weight ◽

Tissue Factor ◽

Low Molecular Weight ◽

Tissue Factor Pathway ◽

Dose Dependent

A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans

Blood Coagulation & Fibrinolysis ◽

10.1097/00001721-199809000-00009 ◽

1998 ◽

Vol 9 (6) ◽

pp. 517-524 ◽

Cited By ~ 3

Author(s):

B. Kaiser ◽

E. Glusa ◽

D. A. Hoppensteadt ◽

H. K. Breddin ◽

J. Amiral ◽

...

Keyword(s):

Molecular Weight ◽

Tissue Factor ◽

Plasma Levels ◽

Subcutaneous Administration ◽

Low Molecular Weight ◽

Tissue Factor Pathway ◽

Total Tissue

Tissue Factor Pathway Inhibitor Release is Specific for Heparin and Low Molecular Weight Heparins. Implications in the Management of Coronary Syndromes

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)83938-1 ◽

1998 ◽

Vol 31 (2) ◽

pp. 53A ◽

Cited By ~ 1

Author(s):

D Hoppensteadt

Keyword(s):

Molecular Weight ◽

Tissue Factor ◽

Low Molecular Weight ◽

Coronary Syndromes ◽

Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action

British Journal of Haematology ◽

10.1046/j.1365-2141.1998.00770.x ◽

1998 ◽

Vol 101 (4) ◽

pp. 638-646 ◽

Cited By ~ 36

Author(s):

John‐Bjarne Hansen ◽

Per Morten Sandset ◽

Kirsten Raanaas Huseby ◽

Nils‐Erik Huseby ◽

Bjørn Bendz ◽

...

Keyword(s):

Molecular Weight ◽

Unfractionated Heparin ◽

Tissue Factor ◽

Differential Effect ◽

Low Molecular Weight ◽

Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparin

Thrombosis Research ◽

10.1016/0049-3848(94)90035-3 ◽

1994 ◽

Vol 74 (1) ◽

pp. 53-64 ◽

Cited By ~ 18

Author(s):

Richard Kijowski ◽

Debra Hoppensteadt ◽

Jeanine Walenga ◽

Lars Borris ◽

Michael Rud Lassen ◽

...

Keyword(s):

Molecular Weight ◽

Venous Thrombosis ◽

Deep Venous Thrombosis ◽

Tissue Factor ◽

Low Molecular Weight ◽

Dvt Prophylaxis ◽

Effect of Intraperitoneal Administration of Low-Molecular-Weight Heparin on Plasma Tissue Factor Pathway Inhibitor Levels in CAPD Patients

Nephron ◽

10.1159/000057620 ◽

2002 ◽

Vol 91 (1) ◽

pp. 162-163 ◽

Cited By ~ 3

Author(s):

Fatih Demirkan ◽

Mesut Akarsu ◽

Aykut Sifil ◽

Kutlay Naci Tutucu

Keyword(s):

Molecular Weight ◽

Tissue Factor ◽

Intraperitoneal Administration ◽

Low Molecular Weight ◽